Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of multiple oral doses of PF-06835919 in healthy adult Japanese participants. A total of approximately 8 healthy participants will be enrolled in this study. Participants will be randomized to 2 groups to receive PF-06835919 or placebo treatment with a randomization ratio of 3:1.
Epistemonikos ID: ca39a373f687817790cc9eea83a5b3ea8e0b88b1
First added on: May 07, 2024